Published in Am J Pathol on September 01, 2000
Catalytically inactive human cathepsin D triggers fibroblast invasive growth. J Cell Biol (2005) 1.22
Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor. Am J Pathol (2001) 1.17
Telomere attrition in isolated high-grade prostatic intraepithelial neoplasia and surrounding stroma is predictive of prostate cancer. Neoplasia (2007) 1.00
Phenotypic switch from paracrine to autocrine role of hepatocyte growth factor in an androgen-independent human prostatic carcinoma cell line, CWR22R. Am J Pathol (2004) 0.96
SF/HGF-c-Met autocrine and paracrine promote metastasis of hepatocellular carcinoma. World J Gastroenterol (2001) 0.91
Expression of TRPC6 in benign and malignant human prostate tissues. Asian J Androl (2009) 0.86
Prostate tumor cell plasticity: a consequence of the microenvironment. Adv Exp Med Biol (2011) 0.84
Circulating fibroblast-like cells in men with metastatic prostate cancer. Prostate (2012) 0.80
Spatially restricted Hedgehog signalling regulates HGF-induced branching of the adult prostate. Nat Cell Biol (2014) 0.80
Differences in phenotype and gene expression of prostate stromal cells from patients of varying ages and their influence on tumour formation by prostate epithelial cells. Asian J Androl (2011) 0.78
Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol (1979) 6.96
A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell Dev Biol Anim (1999) 4.93
Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun (1984) 3.70
Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc Natl Acad Sci U S A (1990) 2.34
Control of hepatocyte replication by two serum factors. Cancer Res (1984) 2.20
Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res (1997) 2.06
Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. Am J Pathol (1995) 1.94
Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Am J Pathol (1994) 1.94
Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res (1991) 1.87
c-met proto-oncogene expression in benign and malignant human prostate tissues. J Urol (1995) 1.83
Androgen receptors in endocrine-therapy-resistant human prostate cancer. Int J Cancer (1991) 1.81
Distant metastases from prostatic carcinoma express androgen receptor protein. Cancer Res (1995) 1.63
Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am J Pathol (1996) 1.58
Partial characterization of a hepatocyte growth factor from rat platelets. J Cell Physiol (1984) 1.56
Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer (1997) 1.50
Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res (1995) 1.40
Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer. Cancer Res (1997) 1.36
Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells. Cell Growth Differ (1993) 1.36
Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis. Am J Pathol (1995) 1.27
Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6. Int J Cancer (1996) 1.13
Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor. Oncogene (1998) 1.09
Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo. Cancer Res (1998) 1.09
Hepatocyte growth factor/scatter factor expression in human mammary epithelium. Am J Pathol (1994) 1.07
Interaction between prostatic fibroblast and epithelial cells in culture: role of androgen. Endocrinology (1989) 1.06
Transforming growth factor-beta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells. Jpn J Cancer Res (1997) 1.04
Expression of scatter factor in human bladder carcinoma. J Natl Cancer Inst (1995) 0.94
Acquisition of invasive phenotype in gallbladder cancer cells via mutual interaction of stromal fibroblasts and cancer cells as mediated by hepatocyte growth factor. Jpn J Cancer Res (1996) 0.88
Evaluation of mixed chimaerism and origin of bone marrow derived fibroblastoid cells after allogeneic bone marrow transplantation. Br J Haematol (1994) 0.87
Keratinocyte growth factor expression in hormone insensitive prostate cancer. Oncogene (1997) 0.86
Activation-induced expression of vascular permeability factor by human peripheral T cells: a non-radioisotopic semiquantitative reverse transcription-polymerase chain reaction assay. J Immunol Methods (1996) 0.86
Co-expression of hepatocyte growth factor and its receptor in human prostate cancer. Histochem J (1998) 0.85
Reconstruction of prostatic acinus-like structure from ventral and dorsolateral prostatic epithelial cells of the rat in three-dimensional collagen gel matrix culture. J Urol (1997) 0.83
Stromal inhibition of epithelial cell growth in the prostate; overview of an experimental study. Urol Res (1997) 0.82
Inhibition of prostatic epithelial cell proliferation by a factor secreted specifically by prostatic stromal cells. Prostate (1995) 0.78
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. Science (1999) 6.77
Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons. Cell (2001) 6.00
Frequent allelic loss of the RB, D13S319 and D13S25 locus in myeloid malignancies with deletion/translocation at 13q14 of chromosome 13, but not in lymphoid malignancies. Leukemia (1999) 5.02
A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc Natl Acad Sci U S A (1999) 4.46
Clonal origin bladder cancer. N Engl J Med (1992) 3.97
Clinical evaluation of cerebral oxygen balance during cardiopulmonary bypass: on-line continuous monitoring of jugular venous oxyhemoglobin saturation. Anesth Analg (1992) 3.72
Rim is a putative Rab3 effector in regulating synaptic-vesicle fusion. Nature (1997) 3.63
Tobacco MAP kinase: a possible mediator in wound signal transduction pathways. Science (1995) 3.56
Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med (1988) 3.50
Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell (2001) 3.49
Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab (2001) 3.43
Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci U S A (1997) 3.37
Isolation of mutants of Schizosaccharomyces pombe unable to synthesize cadystin, small cadmium-binding peptides. Biochem Biophys Res Commun (1988) 3.09
A tripartite protein complex with the potential to couple synaptic vesicle exocytosis to cell adhesion in brain. Cell (1998) 3.05
Postnatal synaptic potentiation: delivery of GluR4-containing AMPA receptors by spontaneous activity. Nat Neurosci (2000) 2.95
Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut (2003) 2.71
Human colonic adenocarcinoma cells. I. Establishment and description of a new line. In Vitro (1976) 2.65
Two-photon imaging in living brain slices. Methods (1999) 2.53
Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature (1992) 2.52
Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol (2003) 2.52
Direct interaction of the rat unc-13 homologue Munc13-1 with the N terminus of syntaxin. J Biol Chem (1997) 2.50
Identification of amino acid sequences in the integrin beta 1 cytoplasmic domain implicated in cytoskeletal association. J Cell Biol (1992) 2.44
Dog and rat pancreatic phospholipases A2: complete amino acid sequences deduced from complementary DNAs. J Biochem (1986) 2.36
Natural history of polypoid lesions in the gall bladder. Gut (1996) 2.33
Evaluation of polydimethylsiloxane as an alternative in the endoscopic treatment of vesicoureteral reflux. J Urol (1994) 2.29
Coordination of microtubules and the actin cytoskeleton by the Rho effector mDia1. Nat Cell Biol (2001) 2.27
Cloning and expression of cDNA for a human thromboxane A2 receptor. Nature (1991) 2.26
DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat Genet (1997) 2.18
Erythrocyte antioxidant enzymes are reduced in patients with rheumatoid arthritis. J Rheumatol (1988) 2.09
Template activities of the phi X-174 replicative allomorphic deoxyribonucleic acids. Biochemistry (1971) 2.07
Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science (1997) 2.06
PTEN mutations in gliomas and glioneuronal tumors. Oncogene (1998) 2.01
LTP mechanisms: from silence to four-lane traffic. Curr Opin Neurobiol (2000) 2.00
Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res (1997) 1.95
Multilocular cystic renal cell carcinoma. Am J Clin Pathol (1991) 1.95
Regulation of a putative high-affinity nitrate transporter (Nrt2;1At) in roots of Arabidopsis thaliana. Plant J (1999) 1.93
Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat Genet (1998) 1.91
Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine. J Exp Med (1986) 1.89
Semiquantitative grading of severity of mitral regurgitation by real-time two-dimensional Doppler flow imaging technique. J Am Coll Cardiol (1986) 1.86
Spontaneous regression of localized neuroblastoma detected by mass screening. J Clin Oncol (1998) 1.84
Vitrectomy for cystoid macular oedema with attached posterior hyaloid membrane in patients with diabetes. Br J Ophthalmol (1999) 1.80
Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer amyloid protein precursor. Nature (1992) 1.80
Mechanism of ergonovine-induced hyperconstriction of the large epicardial coronary artery in conscious dogs a month after arterial injury. Circ Res (1992) 1.78
An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. Cancer Res (1994) 1.77
Dominant inheritance of resistance to thyroid hormone not linked to defects in the thyroid hormone receptor alpha or beta genes may be due to a defective cofactor. J Clin Endocrinol Metab (1996) 1.75
Narrow band imaging for detecting superficial squamous cell carcinoma of the head and neck in patients with esophageal squamous cell carcinoma. Endoscopy (2010) 1.75
Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype. J Biol Chem (1992) 1.75
Identification of a Gs activator region of the beta 2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation. Cell (1991) 1.74
Microbial Conversion of alpha-Ionone, alpha-Methylionone, and alpha-Isomethylionone. Appl Environ Microbiol (1988) 1.72
A mutant of Chlamydomonas reinhardtii that lacks the flagellar outer dynein arm but can swim. J Cell Sci (1985) 1.71
A phylogenetic hypothesis for the distribution of two genotypes of the pig tapeworm Taenia solium worldwide. Parasitology (2002) 1.70
Detection of new paternal dystrophin gene mutations in isolated cases of dystrophinopathy in females. Am J Hum Genet (1994) 1.70
An immunohistochemical study of developing glomeruli in human fetal kidneys. Kidney Int (2000) 1.69
Brief report: resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene. N Engl J Med (1995) 1.68
The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family. Blood (1998) 1.64
Occurrence of acid-labile sulfide in cadmium-binding peptide 1 from fission yeast. J Biochem (1983) 1.64
Motoneuron-specific expression of NR3B, a novel NMDA-type glutamate receptor subunit that works in a dominant-negative manner. J Neurosci (2001) 1.63
Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13). Blood (1997) 1.63
Clinical features of 53 cases with pustulotic arthro-osteitis. Ann Rheum Dis (1981) 1.62
Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol (2001) 1.61
Superior outcome of infant acute myeloid leukemia with intensive chemotherapy: results of the Japan Infant Leukemia Study Group. Blood (2001) 1.61
Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations. Leukemia (2009) 1.60
Thyroid hormone action on liver, heart, and energy expenditure in thyroid hormone receptor beta-deficient mice. Endocrinology (1998) 1.60
Do the kinetics of peripheral muscle oxygenation reflect systemic oxygen intake? Eur J Appl Physiol (2001) 1.60
PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma. Oncogene (2011) 1.59
Membrane protein molecular weight determined by low-angle laser light-scattering photometry coupled with high-performance gel chromatography. Methods Enzymol (1989) 1.59
Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Res (1992) 1.57
Oral administration of the renal carcinogen, potassium bromate, specifically produces 8-hydroxydeoxyguanosine in rat target organ DNA. Carcinogenesis (1987) 1.57
Carcinoma of the ampulla of Vater: expression of cancer-associated antigens inversely correlated with prognosis. Am J Gastroenterol (1988) 1.57
Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients. Am J Surg Pathol (1999) 1.55
Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007. Vaccine (2009) 1.55
Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J Biol Chem (1995) 1.55
The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1. Mol Cell Biol (1998) 1.55
Molecular characterization of a new metabotropic glutamate receptor mGluR7 coupled to inhibitory cyclic AMP signal transduction. J Biol Chem (1994) 1.54
Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia. Leuk Res (1999) 1.54
Thoracic epidural anesthesia attenuates halothane-induced myocardial sensitization to dysrhythmogenic effect of epinephrine in dogs. Anesthesiology (1995) 1.53
The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. Blood (1997) 1.52
Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism. Hypertension (1997) 1.51
Augmentation of atrial contribution to left ventricular inflow with aging as assessed by intracardiac Doppler flowmetry. Am J Cardiol (1984) 1.51
hCDC47, a human member of the MCM family. Dissociation of the nucleus-bound form during S phase. J Biol Chem (1996) 1.51
Urokinase type plasminogen activator receptor expression in colorectal neoplasms. Gut (1998) 1.50
Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Am J Pathol (1998) 1.49
Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse. J Exp Med (1994) 1.49
Primary gastric T-cell lymphoma with and without human T-lymphotropic virus type 1. Cancer (1997) 1.49
Identification of two Sox17 messenger RNA isoforms, with and without the high mobility group box region, and their differential expression in mouse spermatogenesis. J Cell Biol (1996) 1.48
Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res (1999) 1.48
Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome. Hum Mol Genet (2001) 1.48
Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells. Am J Pathol (2001) 1.48
Motoneuron-specific NR3B gene: no association with ALS and evidence for a common null allele. Neurology (2007) 1.48
Reduced levels of chloroplast FtsH protein in tobacco mosaic virus-infected tobacco leaves accelerate the hypersensitive reaction. Plant Cell (2000) 1.48
Continuous positive airway pressure breathing in supine and upright postures. Tohoku J Exp Med (1990) 1.47
The oxidation-reduction potentials of compound I/compound II and compound II/ferric couples of horseradish peroxidases A2 and C. J Biol Chem (1979) 1.47
Analysis of mtDNA sequences shows Japanese native chickens have multiple origins. Anim Genet (2007) 1.47
Prolonged hoarseness and arytenoid cartilage dislocation after tracheal intubation. Br J Anaesth (2009) 1.45
Super high resolution for single molecule-sequence-based typing of classical HLA loci at the 8-digit level using next generation sequencers. Tissue Antigens (2012) 1.44